Jonathan Newman

Personal Information
Title Assistant Professor
Expertise Cardiovascular
Institution New York University School of Medicine
Data Summary
TypeCount
Grants/SubContracts 1
Progress Reports 1
Publications 5
Protocols 0
Committees 2

SubContract(s)


Arsenic Exposure, Endothelial Function and Platelet Activity in Type 2 Diabetes
Despite optimal medical therapy to reduce cardiovascular disease (CVD) risk, patients with type 2 diabetes (T2D) have a significantly greater risk of CVD than patients without T2D. Data from the prospective NIH/NHLBI Strong Heart Study suggested low to moderate inorganic arsenic exposure may be a novel risk factor for CVD, especially for patients with T2D. In the United States, exposure to inorganic arsenic at low to moderate levels is common, with millions of people exposed annually in the U.S. through food and drinking water. However, the mechanisms by which low to moderate arsenic exposure may increase CVD risk in patients with T2D have not been characterized. Therefore, our aims are to: (1) investigate whether increasing concentrations of glucose modify the effects of low to moderate concentrations of sodium arsenite on markers of human aortic and coronary endothelial cell dysfunction; and (2) investigate whether increasing concentrations of glucose modify the effects of low to moderate concentrations of sodium arsenite on platelet function and aggregability. This proposal will provide novel insights into the associations among low to moderate arsenic exposure, T2D, markers of endothelial dysfunction and platelet activity for the risk of CVD. These studies would be the first to examine in two model systems the effect of environmental modifiers such as arsenic exposure on the risk of CVD in T2D, and could be used to explore the risk of other environmental exposures as contributors to the excess risk of CVD in patients with T2D.


Progress Reports

Annual Reports

No uploaded documents found.



 PublicationAltmetricsSubmitted ByPubMed IDStatus

Year: 2019; Items: 1
 
Association of Arsenic Exposure With Cardiac Geometry and Left Ventricular Function in Young Adults.
Pichler G, Grau-Perez M, Tellez-Plaza M, Umans J, Best L, Cole S, Goessler W, Francesconi K, Newman J, Redon J, Devereux R, Navas-Acien A
Circulation. Cardiovascular imaging, 2019 (12), e009018
Newman, Jonathan
31060373
Published

Year: 2017; Items: 3
 
Hyperglycemia enhances arsenic-induced platelet and megakaryocyte activation.
Newman JD, Echagarruga CT, Ogando YM, Montenont E, Chen Y, Fisher EA, Berger JS
Journal of translational medicine, 2017 (15), 55
Newman, Jonathan
28264687
Published
 
Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study.
Moon KA, Navas-Acien A, Grau-Pérez M, Francesconi KA, Goessler W, Guallar E, Umans JG, Best LG, Newman JD
PLoS ONE, 2017 (12), e0182435
Newman, Jonathan
28771557
Published
 
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS
Journal of the American College of Cardiology, 2017 (70), 883 - 893
Newman, Jonathan
28797359
Published

Year: 2016; Items: 1
 
Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study.
Newman JD, Navas-Acien A, Kuo CC, Guallar E, Howard BV, Fabsitz RR, Devereux RB, Umans JG, Francesconi KA, Goessler W, Best LT, Tellez-Plaza M
American journal of epidemiology, 2016 (184), 806 - 817
Newman, Jonathan
27810857
Published

No uploaded documents found.

No protocols found.

No experiments found.